|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.810 CNY | -0.11% |
|
-3.93% | -29.86% |
| 07-27 | KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs | MT |
| 04-24 | KPC Pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 6.67B 988M 856M 800M 731M 1.38B 94.27B 1.4B 9.38B 3.68B 47.16B 3.71B 3.63B 157B | P/E 2026 * |
22.8x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 988M 856M 800M 731M 1.38B 94.27B 1.4B 9.38B 3.68B 47.16B 3.71B 3.63B 157B | EV / Sales 2026 * |
0.98x | EV / Sales 2027 * | 0.92x |
| Free-Float |
60.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.11% | ||
| 1 week | -3.93% | ||
| Current month | -2.87% | ||
| 1 month | +6.40% | ||
| 3 months | -6.77% | ||
| 6 months | -29.41% | ||
| Current year | -29.86% |
| 1 week | 8.58 |  | 9.08 |
| 1 month | 8.29 | | 9.3 |
| Current year | 7.45 | | 13.55 |
| 1 year | 7.45 | | 14.98 |
| 3 years | 7.45 | | 24.11 |
| 5 years | 7.45 | | 26.09 |
| 10 years | 5.95 | | 26.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Sun
DFI | Director of Finance/CFO | - | 2023-01-02 |
Wei Yan
PSD | President | 55 | 2023-09-27 |
Wen Sen Zhang
PRN | Corporate Officer/Principal | 54 | 2007-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Liu
BRD | Director/Board Member | 74 | 2018-11-01 |
Lin Xi Li
BRD | Director/Board Member | 50 | 2018-11-01 |
Wen Sen Zhang
BRD | Director/Board Member | 54 | 2018-11-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | -3.93% | -39.53% | -46.25% | 989M | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,057B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 625B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 435B | |
| +1.58% | +4.80% | +51.42% | +39.79% | 363B | |
| +0.65% | +1.85% | +34.81% | +39.99% | 296B | |
| +0.79% | +4.26% | +9.78% | +7.42% | 249B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 222B | |
| +0.34% | +1.27% | -5.23% | -50.94% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +1.03% | +2.52% | +28.06% | +36.76% | 362.18B | |
| Weighted average by Cap. | +1.78% | +4.76% | +51.74% | +67.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.8B 1.01B 873M 816M 745M 1.4B 96.13B 1.43B 9.56B 3.75B 48.09B 3.78B 3.7B 160B | 7.25B 1.07B 930M 869M 795M 1.5B 102B 1.52B 10.2B 4B 51.27B 4.03B 3.95B 171B |
| Net income | 294M 43.59M 37.74M 35.27M 32.24M 60.75M 4.16B 61.7M 414M 162M 2.08B 164M 160M 6.93B | 366M 54.3M 47M 43.93M 40.15M 75.67M 5.18B 76.85M 515M 202M 2.59B 204M 199M 8.63B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | CN¥8.810 | -0.11% | 10,977,556 |
| 26-08-07 | CN¥8.820 | +0.80% | 7,935,754 |
| 26-08-06 | CN¥8.750 | -0.79% | 10,818,727 |
| 26-08-05 | CN¥8.820 | -2.65% | 13,493,792 |
| 26-08-04 | CN¥9.060 | -1.20% | 7,701,320 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600422 Stock
Select your edition
All financial news and data tailored to specific country editions
